Sunflower Pharmaceuticals Group Co Ltd (002737) — Net Asset Quality Index
Sunflower Pharmaceuticals Group Co Ltd (002737) has a Net Asset Quality Index of 76.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.36 Billion minus total liabilities of CN¥1.25 Billion yields net assets of CN¥4.11 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of Sunflower Pharmaceuticals Group Co Ltd to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sunflower Pharmaceuticals Group Co Ltd Net Asset Quality Index Over Time (2011–2025)
This chart shows how Sunflower Pharmaceuticals Group Co Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 76.7%, representing net assets of CN¥4.11 Billion against total assets of CN¥5.36 Billion CNY. Explore Sunflower Pharmaceuticals Group Co Ltd cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Sunflower Pharmaceuticals Group Co Ltd (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Sunflower Pharmaceuticals Group Co Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.9% | CN¥3.99 Billion | CN¥5.33 Billion | CN¥1.34 Billion | ▼ -3.9 pp |
| 2024 | 78.8% | CN¥4.59 Billion | CN¥5.83 Billion | CN¥1.24 Billion | ▲ +6.1 pp |
| 2023 | 72.7% | CN¥5.00 Billion | CN¥6.88 Billion | CN¥1.88 Billion | ▲ +9.6 pp |
| 2022 | 63.1% | CN¥4.44 Billion | CN¥7.03 Billion | CN¥2.59 Billion | ▼ -6.7 pp |
| 2021 | 69.8% | CN¥3.94 Billion | CN¥5.64 Billion | CN¥1.70 Billion | ▲ +3.5 pp |
| 2020 | 66.3% | CN¥3.39 Billion | CN¥5.11 Billion | CN¥1.72 Billion | ▲ +1.7 pp |
| 2019 | 64.6% | CN¥3.43 Billion | CN¥5.31 Billion | CN¥1.88 Billion | ▼ -3.3 pp |
| 2018 | 67.9% | CN¥3.44 Billion | CN¥5.06 Billion | CN¥1.62 Billion | ▼ -2.8 pp |
| 2017 | 70.7% | CN¥3.16 Billion | CN¥4.47 Billion | CN¥1.31 Billion | ▲ +4.3 pp |
| 2016 | 66.4% | CN¥2.80 Billion | CN¥4.22 Billion | CN¥1.42 Billion | ▼ -2.9 pp |
| 2015 | 69.3% | CN¥2.61 Billion | CN¥3.76 Billion | CN¥1.15 Billion | ▲ +8.3 pp |
| 2014 | 61.1% | CN¥2.28 Billion | CN¥3.73 Billion | CN¥1.45 Billion | ▲ +19.7 pp |
| 2013 | 41.4% | CN¥869.02 Million | CN¥2.10 Billion | CN¥1.23 Billion | ▲ +1.4 pp |
| 2012 | 40.0% | CN¥758.39 Million | CN¥1.89 Billion | CN¥1.14 Billion | ▲ +5.1 pp |
| 2011 | 34.9% | CN¥543.47 Million | CN¥1.56 Billion | CN¥1.01 Billion | — |